Stay updated on KarXT for Schizophrenia: Long-term Clinical Trial
Sign up to get notified when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.

Latest updates to the KarXT for Schizophrenia: Long-term Clinical Trial page
- Check5 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Schizophrenia, expanding the page's scope to include genetics-related information on schizophrenia.SummaryDifference0.1%
- Check12 days agoChange DetectedMajor update to page status notice and version; removal of a genetics topic balanced by an explicit operating-status message and version bump.SummaryDifference2%
- Check20 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%
- Check27 days agoChange DetectedExpanded study details: many new locations and topic topics added, plus updated results timelines and key efficacy/adverse-event endpoints; older, broader outcome descriptions removed. Overall core content and stakeholder-facing details grow significantly.SummaryDifference71%
- Check34 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check41 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the section on Schizophrenia related topics from MedlinePlus Genetics has been deleted.SummaryDifference0.3%
Stay in the know with updates to KarXT for Schizophrenia: Long-term Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.